Over time, this myeloproliferative phenotype transitions to a chronic myeloid leukemia (CML)-like syndrome in a significant fraction of IRF8-null mice [7]. Here, IRF8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.